Evidence map›Paper›PMID 35303189›Full record

ArticleAIDS and behavior2022

Substance Use, Violence, and Sexual Risk Among Young Cis-Gender Women Placed at High-Risk for Human Immunodeficiency Virus Infection.

Gabriella Vavala, Qiao Wang, Sergio Jimenez, Wilson E Ramos, Manuel A Ocasio, Adriana Romero-Espinoza, Risa Flynn, Robert Bolan, M Isabel Fernandez, Pearl Doan and 4 more

Abstract read
In one paragraph

Article in AIDS and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Gabriella VavalaDivision of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. gabriellavavala@hsph.harvard.edu.ORCID http://orcid.org/0000-0002-3491-0286
Qiao WangDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, USA.
Sergio JimenezDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Wilson E RamosDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Manuel A OcasioDepartment of Pediatrics/ Section of Adolescent Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
Adriana Romero-EspinozaDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Risa FlynnLos Angeles LGBT Center, Los Angeles, CA, USA.
Robert BolanLos Angeles LGBT Center, Los Angeles, CA, USA.
M Isabel FernandezNova Southeastern University, Fort Lauderdale, FL, USA.
Pearl DoanDivision of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Elizabeth Mayfield ArnoldDepartment of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Dallas SwendemanDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
W Scott ComuladaDepartment of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Jeffrey D KlausnerPopulation and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
Optimizing the HIV Treatment Continuum with a Stepped Care Model for Youth Living with HIVU19HD089886 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FERNANDEZ, MARIA ISABEL, ROTHERAM-BORUS, MARY JANE · 2016 to 2022
$23.4M
Eunice Kennedy Shriver National Institute of Child Health and Human Development U19HD089886NICHD NIH HHS U19 HD089886NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

The substance use, violence, and AIDS (SAVA) syndemic framework is used to study risk for HIV/AIDS. As a secondary analysis from a large HIV/AIDS prevention study, we categorized participants into having from zero to three SAVA conditions based on the presence or absence of self-reported substance use in the past 4 months, history of lifetime sexual abuse, and intimate partner violence. We used Poisson regression models to examine the association between the number of SAVA conditions and sexual risk behavior. Among all participants (n = 195, median age, 20), 37.9%, 19.5%, and 6.7% reported occurrence of one, two, and all three SAVA conditions, respectively. We found that more than one SAVA condition experienced by women was significantly associated with having more than one sex partner (adjusted prevalence ratio [aPR] = 1.88; 95% confidence interval [CI] = 1.28, 2.76) and with substance use before sex (aPR = 1.61 95% CI = 1.06, 2.45).

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsIntimate Partner ViolenceSubstance-Related DisordersAdultFemaleHumansPrevalenceSexual BehaviorSexual PartnersViolenceYoung Adult

Identifiers

PMID35303189
PMCPMC10003641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.